Prediction of NEC With Urinary iFABP

Withdrawn before enrolling · Phase 2

Conditions studied: Prematurity, Necrotizing Enterocolitis

In brief

During the first four days of life, intestinal fatty acid binding protein (iFABP) is elevated in the urine of premature babies who go on to develop necrotizing enterocolitis (NEC) days to weeks later. This study aims to determine whether the withholding of feedings in babies with an elevated urinary iFABP can reduce the incidence of NEC.

Key facts

Study ID

NCT01805206

Run by

Loma Linda University

People needed

0

Starts

2014-11-01

Expected to finish

2016-07-01

Last updated by the study team

2015-05-14

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Gestational age less than 33 weeks
• Admission to Loma Linda University Children's Hospital NICU within 48 hours of life

You may not qualify if…

• Anuria
• Congenital gastrointestinal anomaly

Where it is running

• Loma Linda University Children's Hospital — Loma Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.